Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.

Wang Y, Ewig CLY, Smolinski NE, Toyserkani GA, LaCivita C, Zhou EH, Dal Pan GJ, Thai TN, Maro JC, Rasmussen SA, Winterstein AG

Open source

DOI
10.1007/s40264-026-01653-x
Published
2026 Jul
Container
Drug safety
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40264-026-01653-x,
  title = {Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.},
  author = {Wang Y and Ewig CLY and Smolinski NE and Toyserkani GA and LaCivita C and Zhou EH and Dal Pan GJ and Thai TN and Maro JC and Rasmussen SA and Winterstein AG},
  year = {2026},
  journal = {Drug safety},
  doi = {10.1007/s40264-026-01653-x},
  url = {https://doi.org/10.1007/s40264-026-01653-x}
}

RIS

TY  - JOUR
TI  - Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.
AU  - Wang Y
AU  - Ewig CLY
AU  - Smolinski NE
AU  - Toyserkani GA
AU  - LaCivita C
AU  - Zhou EH
AU  - Dal Pan GJ
AU  - Thai TN
AU  - Maro JC
AU  - Rasmussen SA
AU  - Winterstein AG
PY  - 2026
JO  - Drug safety
DO  - 10.1007/s40264-026-01653-x
UR  - https://doi.org/10.1007/s40264-026-01653-x
ER  - 

APA

Y, W., CLY, E., NE, S., GA, T., C, L., EH, Z., GJ, D. P., TN, T., JC, M., SA, R., & AG, W. (2026). Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.. Drug safety. https://doi.org/10.1007/s40264-026-01653-x

Source records